日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial

研究概要:阿普米司特治疗日本掌跖脓疱病患者:一项随机、3期临床试验

Terui, Tadashi; Okubo, Yukari; Kobayashi, Satomi; Morita, Akimichi; Imafuku, Shinichi; Tada, Yayoi; Abe, Masatoshi; Strober, Bruce; Gooderham, Melinda; Hara, Yasuhito; Zhang, Wendy; Shimauchi, Junichiro; Yaguchi, Masafumi; Kimura, Takeshi; Ogawa, Ryuichi; Amouzadeh, Hamid; Murakami, Masamoto

Complications and Laboratory Test Findings Among Patients With Generalized Pustular Psoriasis: A Retrospective Chart Review Study

泛发性脓疱型银屑病患者的并发症和实验室检查结果:一项回顾性病历分析研究

Okuyama, Ryuhei; Okubo, Yukari; Imafuku, Shinichi; Tada, Yayoi; Yamanaka, Keiichi; Sugiura, Kazumitsu; Yamaguchi, Yukie; Yasuda, Masahito; Sakamoto, Wataru; Saitoh, Morihisa; Morita, Akimichi

Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP)

Spesolimab治疗泛发性脓疱型银屑病的真实世界安全性概况:来自日本作为多国扩大用药计划(EAP)一部分的见解

Morita, Akimichi; Tada, Yayoi; Tsunemi, Yuichiro; Komine, Mayumi; Kanekura, Takuro; Imafuku, Shinichi; Takahashi, Toshiya; Ding, Xuemei; Pillai, Nichiren; Saitoh, Morihisa; Simoes, Rafael Sani; Pöntynen, Nora; Yamanaka, Keiichi

Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long-Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod-Induced Psoriasiform Dermatitis

马沙骨化醇/倍他米松丁酸丙酸酯复方软膏具有长期持续诱导调节性T细胞和下调Th17反应的作用,即使在停用后,该作用仍能维持在咪喹莫特诱导的银屑病样皮炎中的疗效。

Shimizu, Teruo; Kamata, Masahiro; Uratsuji, Hideya; Okada, Yoshiki; Watanabe, Ayu; Hiura, Azusa; Tomura, Yayoi; Tada, Yayoi

Real-world effectiveness and safety of lebrikizumab maintenance dosing every 4 weeks starting at week 4 after 2 loading doses in Japanese patients with atopic dermatitis

在日本特应性皮炎患者中,接受2次负荷剂量后,从第4周开始每4周给予一次lebrikizumab维持治疗的真实世界疗效和安全性

Okada, Yoshiki; Kamata, Masahiro; Suzuki, Shoya; Watanabe, Ayu; Chijiwa, Chika; Tomura, Yayoi; Takeshima, Ryosuke; Hiura, Azusa; Hayashi, Kotaro; Fukuyasu, Atsuko; Tanaka, Takamitsu; Ishikawa, Takeko; Tada, Yayoi

Blood DNA virome associates with autoimmune diseases and COVID-19.

血液DNA病毒组与自身免疫性疾病和COVID-19相关。

Sasa Noah, Kojima Shohei, Koide Rie, Hasegawa Takanori, Namkoong Ho, Hirota Tomomitsu, Watanabe Rei, Nakamura Yuumi, Oguro-Igashira Eri, Ogawa Kotaro, Yata Tomohiro, Sonehara Kyuto, Yamamoto Kenichi, Kishikawa Toshihiro, Sakaue Saori, Edahiro Ryuya, Shirai Yuya, Maeda Yuichi, Nii Takuro, Chubachi Shotaro, Tanaka Hiromu, Yabukami Haruka, Suzuki Akari, Nakajima Kimiko, Arase Noriko, Okamoto Takashi, Nishikawa Rika, Namba Shinichi, Naito Tatsuhiko, Miyagawa Ippei, Tanaka Hiroaki, Ueno Masanobu, Ishitsuka Yosuke, Furuta Junichi, Kunimoto Kayo, Kajihara Ikko, Fukushima Satoshi, Miyachi Hideaki, Matsue Hiroyuki, Kamata Masahiro, Momose Mami, Bito Toshinori, Nagai Hiroshi, Ikeda Tetsuya, Horikawa Tatsuya, Adachi Atsuko, Matsubara Tsukasa, Ikumi Kyoko, Nishida Emi, Nakagawa Ikuma, Yagita-Sakamaki Mayu, Yoshimura Maiko, Ohshima Shiro, Kinoshita Makoto, Ito Satoru, Arai Toru, Hirose Masaki, Tanino Yoshinori, Nikaido Takefumi, Ichiwata Toshio, Ohkouchi Shinya, Hirano Taizou, Takada Toshinori, Tazawa Ryushi, Morimoto Konosuke, Takaki Masahiro, Konno Satoshi, Suzuki Masaru, Tomii Keisuke, Nakagawa Atsushi, Handa Tomohiro, Tanizawa Kiminobu, Ishii Haruyuki, Ishida Manabu, Kato Toshiyuki, Takeda Naoya, Yokomura Koshi, Matsui Takashi, Uchida Akifumi, Inoue Hiromasa, Imaizumi Kazuyoshi, Goto Yasuhiro, Kida Hiroshi, Fujisawa Tomoyuki, Suda Takafumi, Yamada Takashi, Satake Yasuomi, Ibata Hidenori, Saigusa Mika, Shirai Toshihiro, Hizawa Nobuyuki, Nakata Koh, Imafuku Shinichi, Tada Yayoi, Asano Yoshihide, Sato Shinichi, Nishigori Chikako, Jinnin Masatoshi, Ihn Hironobu, Asahina Akihiko, Saeki Hidehisa, Kawamura Tatsuyoshi, Shimada Shinji, Katayama Ichiro, Poisner Hannah M, Mack Taralynn M, Bick Alexander G, Higasa Koichiro, Okuno Tatsusada, Mochizuki Hideki, Ishii Makoto, Koike Ryuji, Kimura Akinori, Noguchi Emiko, Sano Shigetoshi, Inohara Hidenori, Fujimoto Manabu, Inoue Yoshikazu, Yamaguchi Etsuro, Ogawa Seishi, Kanai Takanori, Morita Akimichi, Matsuda Fumihiko, Tamari Mayumi, Kumanogoh Atsushi, Tanaka Yoshiya, Ohmura Koichiro, Fukunaga Koichi, Imoto Seiya, Miyano Satoru, Parrish Nicholas F, Okada Yukinori

Whole-genome sequencing reveals rare and structural variants contributing to psoriasis and identifies CERCAM as a risk gene.

全基因组测序揭示了导致银屑病的罕见结构变异,并将 CERCAM 确定为风险基因。

Sonehara Kyuto, Watanabe Rei, Matsumura Yutaka, Mitsui Yuichi, Ogawa Yosuke, Odomari Kaori, Sakaue Saori, Namba Shinichi, Komuro Mariko, Edamoto Mio, Watanabe Junya, Hirota Tomomitsu, Arase Noriko, Nakamura Yuumi, Nakajima Kimiko, Okamoto Takashi, Nishikawa Rika, Yamamoto Kenichi, Suzuki Ken, Kishikawa Toshihiro, Edahiro Ryuya, Shirai Yuya, Naito Tatsuhiko, Sasa Noah, Ishitsuka Yosuke, Furuta Junichi, Kunimoto Kayo, Kajihara Ikko, Fukushima Satoshi, Miyachi Hideaki, Matsue Hiroyuki, Kamata Masahiro, Momose Mami, Miyagawa Ippei, Tanaka Hiroaki, Ueno Masanobu, Bito Toshinori, Nagai Hiroshi, Ikeda Tetsuya, Horikawa Tatsuya, Adachi Atsuko, Matsubara Tsukasa, Nishida Emi, Matsuda Koichi, Shojima Nobuhiro, Nakagawa Ikuma, Asano Yoshihide, Sato Shinichi, Imafuku Shinichi, Tada Yayoi, Nishigori Chikako, Jinnin Masatoshi, Ihn Hironobu, Asahina Akihiko, Saeki Hidehisa, Yamauchi Toshimasa, Kadowaki Takashi, Kawamura Tatsuyoshi, Shimada Shinji, Katayama Ichiro, Higasa Koichiro, Noguchi Emiko, Sano Shigetoshi, Tanaka Yoshiya, Matsuda Fumihiko, Kumanogoh Atsushi, Tamari Mayumi, Satoh Takashi, Fujimoto Manabu, Morita Akimichi, Okada Yukinori

Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions

更正:对 Spesolimab 治疗皮肤病和非皮肤病的试验中预定义安全性事件的分析

Gordon, Kenneth B; Tada, Yayoi; Anadkat, Milan J; Choon, Siew Eng; Elewski, Boni; Barker, Jonathan N; Mostaghimi, Arash; Eyerich, Kilian; Tang, Ming; Haeufel, Thomas; Thoma, Christian; Thaçi, Diamant

Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions

对 Spesolimab 治疗皮肤病和非皮肤病的试验中预定义安全性事件的分析

Gordon, Kenneth B; Tada, Yayoi; Anadkat, Milan J; Choon, Siew Eng; Elewski, Boni; Barker, Jonathan N; Mostaghimi, Arash; Eyerich, Kilian; Tang, Ming; Haeufel, Thomas; Thoma, Christian; Thaçi, Diamant

Efficacy and Safety of Bimekizumab in Japanese Patients with Generalised Pustular Psoriasis and Erythrodermic Psoriasis: 3-Year Results from BE BRIGHT, a Multicentre, Open-Label, Phase 3 Study

比美珠单抗治疗日本泛发性脓疱型银屑病和红皮病型银屑病患者的疗效和安全性:一项多中心、开放标签的3期临床试验BE BRIGHT的3年结果

Okubo, Yukari; Tada, Yayoi; Takahashi, Hidetoshi; Abe, Masatoshi; Yamanaka, Keiichi; Tilt, Nicola; Cross, Nancy; Deherder, Delphine; Matano, Mizuho; Nakagawa, Hidemi